Equillium presents translational data demonstrating impact of itolizumab on effector t cell function at the 2020 american society of hematology annual meeting and exposition

Studies further support itolizumab's potential as treatment for agvhd patients studies further support itolizumab's potential as treatment for agvhd patients

EQ Ratings Summary

EQ Quant Ranking